Literature DB >> 23386004

The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.

Paolo Salvalaggio1, Rogerio Carballo Afonso, Luiz Augusto Pereira, Ben-Hur Ferraz-Neto.   

Abstract

OBJECTIVE: The MELD system has not yet been tested as an allocation tool for liver transplantation in the developing countries. In 2006, MELD (Model for End-stage Liver Disease) was launched as a new liver allocation system in São Paulo, Brazil. This study was designed to assess the results of the new allocation policy on waiting list mortality.
METHODS: The State of São Paulo liver transplant database was retrospectively reviewed from July 2003 through July 2009. Patients were divided into those who were transplanted before (Pre-MELD Group) and those who were transplanted after (post-MELD Group) the implementation of the MELD system. Only adult liver transplant candidates were included. Waiting list mortality was the primary endpoint.
RESULTS: The unadjusted death rate in waiting list decreased significantly after the implementation of the MELD system (from 91.2 to 33.5/1,000 patients per year; p<0.0001). Multivariate analysis showed a significant drop in risk of waiting list death for post-MELD patients (HR 0.34; p<0.0001). Currently, 48% of patients are transplanted within 1-year of listing (versus 23% in the pre-MELD era; p<0.0001). Patient and graft survival did not change with MELD implementation.
CONCLUSION: There was a reduction in waiting time and list mortality after implementation of the MELD system in São Paulo. Patients listed in the post-MELD era had a significant reduction in risk for the waiting list mortality. There were no changes in post-transplant outcomes. MELD can be successfully utilized for liver transplant allocation in developing countries.

Entities:  

Mesh:

Year:  2012        PMID: 23386004     DOI: 10.1590/s1679-45082012000300004

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


  6 in total

Review 1.  Liver transplantation: history, outcomes and perspectives.

Authors:  Roberto Ferreira Meirelles Júnior; Paolo Salvalaggio; Marcelo Bruno de Rezende; Andréia Silva Evangelista; Bianca Della Guardia; Celso Eduardo Lourenço Matielo; Douglas Bastos Neves; Fernando Luis Pandullo; Guilherme Eduardo Gonçalves Felga; Jefferson André da Silva Alves; Lilian Amorim Curvelo; Luiz Gustavo Guedes Diaz; Marcela Balbo Rusi; Marcelo de Melo Viveiros; Marcio Dias de Almeida; Pamella Tung Pedroso; Rodrigo Andrey Rocco; Sérgio Paiva Meira Filho
Journal:  Einstein (Sao Paulo)       Date:  2015 Jan-Mar

2.  LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA.

Authors:  Gustavo Pilotto D Sá; Fernando P P Vicentine; Alcides A Salzedas-Netto; Carla Adriana Loureiro de Matos; Luiz R Romero; Dario F P Tejada; Paulo Celso Bosco Massarollo; Gaspar J Lopes-Filho; Adriano M Gonzalez
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

Review 3.  THE IMPACT OF THE MELD SCORE ON LIVER TRANSPLANT ALLOCATION AND RESULTS: AN INTEGRATIVE REVIEW.

Authors:  Ana Claudia Oliveira de Moraes; Priscilla Caroliny de Oliveira; Olival Cirilo Lucena da Fonseca-Neto
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

4.  Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation.

Authors:  Paulo Ricardo Gessolo Lins; Roberto Camargo Narciso; Leonardo Rolim Ferraz; Virgilio Gonçalves Pereira; Ben-Hur Ferraz-Neto; Marcio Dias De Almeida; Bento Fortunato Cardoso Dos Santos; Oscar Fernando Pavão Dos Santos; Júlio Cesar Martins Monte; Marcelino Souza Durão Júnior; Marcelo Costa Batista
Journal:  BMC Nephrol       Date:  2022-08-23       Impact factor: 2.585

Review 5.  HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT.

Authors:  Marcio F Chedid; Cleber R P Kruel; Marcelo A Pinto; Tomaz J M Grezzana-Filho; Ian Leipnitz; Cleber D P Kruel; Leandro A Scaffaro; Aljamir D Chedid
Journal:  Arq Bras Cir Dig       Date:  2017 Oct-Dec

6.  Association between age at diagnosis and degree of liver injury in hepatitis C.

Authors:  Ana Cláudia de Oliveira; Ana Clara Bortotti; Nathália Neves Nunes; Ibrahin A H El Bacha; Edison Roberto Parise
Journal:  Braz J Infect Dis       Date:  2014-06-04       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.